These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9589072)

  • 1. Aureobasidins as new inhibitors of P-glycoprotein in multidrug resistant tumor cells.
    Kurome T; Takesako K; Kato I
    J Antibiot (Tokyo); 1998 Mar; 51(3):353-8. PubMed ID: 9589072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aureobasidins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC-transporter.
    Tiberghien F; Kurome T; Takesako K; Didier A; Wenandy T; Loor F
    J Med Chem; 2000 Jun; 43(13):2547-56. PubMed ID: 10891114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aureobasidin A, an antifungal cyclic depsipeptide antibiotic, is a substrate for both human MDR1 and MDR2/P-glycoproteins.
    Kino K; Taguchi Y; Yamada K; Komano T; Ueda K
    FEBS Lett; 1996 Dec; 399(1-2):29-32. PubMed ID: 8980113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ABC transporters in aureobasidin A resistance.
    Ogawa A; Hashida-Okado T; Endo M; Yoshioka H; Tsuruo T; Takesako K; Kato I
    Antimicrob Agents Chemother; 1998 Apr; 42(4):755-61. PubMed ID: 9559778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precursor directed biosynthesis of aureobasidins.
    Takesako K; Mizutani S; Sakakibara H; Endo M; Yoshikawa Y; Masuda T; Sono-Koyama E; Kato I
    J Antibiot (Tokyo); 1996 Jul; 49(7):676-81. PubMed ID: 8784430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique molecular conformation of aureobasidin A, a highly amide N-methylated cyclic depsipeptide with potent antifungal activity: X-ray crystal structure and molecular modeling studies.
    In Y; Ishida T; Takesako K
    J Pept Res; 1999 May; 53(5):492-500. PubMed ID: 10424343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological properties of aureobasidin A, a cyclic depsipeptide antifungal antibiotic.
    Takesako K; Kuroda H; Inoue T; Haruna F; Yoshikawa Y; Kato I; Uchida K; Hiratani T; Yamaguchi H
    J Antibiot (Tokyo); 1993 Sep; 46(9):1414-20. PubMed ID: 8226319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation, structures, and antifungal activities of new aureobasidins.
    Yoshikawa Y; Ikai K; Umeda Y; Ogawa A; Takesako K; Kato I; Naganawa H
    J Antibiot (Tokyo); 1993 Sep; 46(9):1347-54. PubMed ID: 8226313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC transporter.
    Loor F; Tiberghien F; Wenandy T; Didier A; Traber R
    J Med Chem; 2002 Oct; 45(21):4598-612. PubMed ID: 12361387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syntheses of antifungal aureobasidin A analogs with alkyl chains for structure-activity relationship.
    Kurome T; Inoue T; Takesako K; Kato I
    J Antibiot (Tokyo); 1998 Mar; 51(3):359-67. PubMed ID: 9589073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of the ABC transporter TAP in multidrug-resistant human cancer cell lines.
    Izquierdo MA; Neefjes JJ; Mathari AE; Flens MJ; Scheffer GL; Scheper RJ
    Br J Cancer; 1996 Dec; 74(12):1961-7. PubMed ID: 8980397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP.
    Lempers VJ; van den Heuvel JJ; Russel FG; Aarnoutse RE; Burger DM; Brüggemann RJ; Koenderink JB
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3372-9. PubMed ID: 27001813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers.
    Ford JM
    Eur J Cancer; 1996 Jun; 32A(6):991-1001. PubMed ID: 8763340
    [No Abstract]   [Full Text] [Related]  

  • 14. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
    Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
    Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of micafungin on cytochrome P450 3A4 and multidrug resistance protein 1 activities, and its comparison with azole antifungal drugs.
    Sakaeda T; Iwaki K; Kakumoto M; Nishikawa M; Niwa T; Jin JS; Nakamura T; Nishiguchi K; Okamura N; Okumura K
    J Pharm Pharmacol; 2005 Jun; 57(6):759-64. PubMed ID: 15969931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
    Friche E; Demant EJ; Sehested M; Nissen NI
    Br J Cancer; 1993 Feb; 67(2):226-31. PubMed ID: 8094288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AUR1, a novel gene conferring aureobasidin resistance on Saccharomyces cerevisiae: a study of defective morphologies in Aur1p-depleted cells.
    Hashida-Okado T; Ogawa A; Endo M; Yasumoto R; Takesako K; Kato I
    Mol Gen Genet; 1996 May; 251(2):236-44. PubMed ID: 8668135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical synthesis and biological properties of novel fluorescent antifolates in Pgp- and MRP-overexpressing tumour cell lines.
    Robson C; Wright KA; Twentyman PR; Lambert PA; Griffin RJ
    Biochem Pharmacol; 1998 Oct; 56(7):807-16. PubMed ID: 9774142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of MDR antagonists on the cidal activity of vincristine for cells expressing MDR-1 is superior to those expressing MRP.
    Hosoi E; Hirose M; Hamano S; Morimoto M; Kuroda Y
    Int J Oncol; 1998 Aug; 13(2):343-8. PubMed ID: 9664131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP1A1 induction and CYP3A4 inhibition by the fungicide imazalil in the human intestinal Caco-2 cells-comparison with other conazole pesticides.
    Sergent T; Dupont I; Jassogne C; Ribonnet L; van der Heiden E; Scippo ML; Muller M; McAlister D; Pussemier L; Larondelle Y; Schneider YJ
    Toxicol Lett; 2009 Feb; 184(3):159-68. PubMed ID: 19070657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.